Randomised controlled trial of computer assisted management of hypertension in primary care.

The hypothesis that general practitioners would obtain better outcomes for patients with hypertension using a computer than doctors not using a computer was tested. Sixty family physicians were randomised to two treatment strategies. "Test" physicians completed a data collection form after each visit from a patient with hypertension and mailed the forms to the test centre for processing. Computer feedback on management was mailed to the doctors. This encouraged doctors to apply the "stepped care" protocol, supplied charts of diastolic blood pressure v time, and ranked patients'' diastolic blood pressures by percentile. Letters were mailed to patients to remind them of appointments. "Control" doctors filled out the same data collection forms as test physicians, but neither doctors nor patients received computer feedback. Physicians who used the computer saw more patients per practice than control doctors (test 50 patients, control 40). For all patients the length of follow up was significantly longer in test practices (test 199 days, control 167), and a smaller percentage dropped out of active treatment in test practices (test 37.5%, control 42.1%). For patients with "moderate" hypertension of a baseline diastolic pressure of greater than 104 mm Hg the mean score of the last recorded pressure was below the goal of 90 mm Hg in test practices (88.5 mm Hg), but it failed to reach this goal in control practices (93.3 mm Hg). A greater average reduction of diastolic pressure was achieved in test practices (test 21.7 mm Hg, control 16.7 mm Hg). Though patients with "moderate" hypertension were better controlled in test practices than in control practices, the patients in test practices visited their doctors less often (test 13.3 visits per patient-year, control 17.4 visits). Among patients with newly detected hypertension test practices achieved a greater reduction in diastolic pressure than control practices (test 15.1 mm Hg v control 11.3 mm Hg) and more sustained control of hypertension (test 323 days per patient-year with a diastolic pressure of 90 mm Hg or less v control 259 days).     

硬头鳟巨噬细胞的体外长期培养(简报)

鱼类的巨噬细胞和高等脊椎动物的一样,在吞灭入侵的病原体方面起着极其重要的作用。探索在体外长期培养巨噬细胞的方法,有助于研究巨噬细胞的机能。Braun-Nesje等虽已从硬头鳟(Salmo gairdneri)等鲑科鱼类的头肾中分离出大量的巨噬细胞,并在体外培养了3个月之久,但因细胞不分裂,无法传代。本研究改用组织块培养法和饲养层技术探索长期培养巨噬细胞的方法,并获得成功。迄今巨噬细胞已在体外培养22个月,传代48次。细胞的原代培养分为三组。前两组是单独的脾或头肾的组织培养;第三组是脾与头肾的混合组织培养。培养液是Leibovitz’s L-15,外加20%胎牛血清,100 IU/ml青霉素和100μg/ml链霉素。巨噬细胞的吞噬活力用酵母菌Candida     

大叶杨配囊及胚珠的形成和发育

本文应用细胞化学方法研究了大叶杨胚珠、胚囊的形成和发育过程中核酸、蛋白质及不溶性多糖的分布和消长。大孢子母细胞、大孢子四分体及功能大孢子中含较少不溶性多糖,但却含丰富的RNA和蛋白质。功能大孢子经分裂发育成八核的蓼型胚囊。四核胚囊开始积累细胞质多糖,成熟胚囊中除反足细胞外充满淀粉粒。反足细胞形成后不久即退化。助细胞具多糖性质的丝状器,受精前两个助细胞退化。卵细胞核对Feulgen反应呈负反应。二极核受精前由胚囊中部移向卵器,与卵器接触后融合形成次生核。发育早期的胚珠为厚珠心,双珠被。晚期,内珠被退化,故成熟胚珠为单珠被。四核胚囊时期,珠孔端珠心组织退化,胚囊伸向珠孔形成胚囊喙。合点端珠心组织含丰富的蛋白质和核酸,这一性质与绒毡层性质相似,可能涉及胚囊的营养运输。胚囊的营养来源于子房和胎座细胞内贮存的淀粉粒。     

蚕豆根端细胞核中微核仁的研究

以蚕豆(Vicia faba)根端分生组织细胞为材料研究了微核仁的超微结构和细胞化学特点。结果表明;微核仁是直径0.3—0.5μm 的卵圆形或球形结构。常规染色时,微核仁与集缩染色质的电子密度相仿,但两者之间在结构上没有任何联系。细胞化学研究指出,微核仁含有 RNA 和蛋白质,其结构成分主要是与核仁颗粒组分十分相似的 RNP 颗粒。报道了植物细胞核中微核仁发生于核仁的过程并对微核仁的本质和功能进行了讨论。     

新疆准噶尔盆地三个泉地区几种始新世哺乳类

本文记述了准噶尔盆地北缘三个泉地区依希白拉组中采到的踝节类、蹠行类、全齿类和恐角类化石。根据这些化石,依希白拉组的时代可能和北美中始新世勃力吉期相当。文内,通过文献分析,认为周明镇和胡长康(1956)记述的真恐角兽的前臼齿可能产自三个泉附近的依希白拉组。     

五种水蛭对不同P^H值的生物效应

本文论述了使用常规试验方法研究5种水蛭:宽身舌蛭(Glossiphonia lata)、八目石蛭(Erpobdella octoculata)、光润金线蛭(Whitmania laevis)、尖细金线蛭(Whitmania acranulata)和日本医蛭(Hirudo nipponia)对12个pH值的24—96小时急性生物效应。结果表明:稻田3个种(尖细金线蛭,光润金线蛭和日本医蛭)均较湖泊近岸2个种(八目石蛭和宽身舌蛭)对pH值的变化要敏感,其中尖细金线蛭最敏感(pH6.0—7.2),八目石蛭的忍耐限度最宽(pH4.0—10.5);当pH值在9.5时,稻田3种水蛭的死亡率在40％以上,其中日本医蛭高达70％;当pH值在3.0时,湖泊近岸2种在24小时内全部死亡,日本医蛭仅死亡10％。日本医蛭是华中农村地区一种主要吸血蛭类,生石灰是一种从稻田消灭蛭类的有效手段,然而水的pH值必须不低于8.6。     

冬虫夏草多糖的分子结构与免疫活性

 冬虫夏草多糖(在本文中名为CS-81002)是由冬虫夏草菌Cordyceps sinensis(Berk)Sacc在人工发酵条件下产生的胞外多糖。用凝胶过滤法测出CS-81002的分子量Mr=43kD。CS-81002的单糖组成为Man:Gal:Glc=10.3:3.6:1。甲基化分析和部份酸水解结果表明,CS-81002是多分支的杂多糖,由→6)-Manp-(1→形成主链,大约每10个主链Man残基中,有6个在C3位上被取代(即形成→3,6)-Manp-(1→分支),有4个在位C2上被取代(即形成→2,6-Manp-(1→分支),从而形成侧链。主链中还有少许未被取代的Man残基。侧链则由→3-)-Galf-(1→,→4)-Glcf-(1→,→4)-Manp-(1→和→2)-Manp-(1→组成。位于非还原末端的,则三种单糖残基都有。CS-81002在5mg/kg体重×12剂量条件下,对正常的昆明小鼠腹腔巨噬细胞吞噬功能有显著促进作用。在同样剂量条件下,对正常LACA小鼠脾脏溶血斑形成细胞(PFC)对绵羊红细胞的溶血作用无显著影响。不同程度的部份酸水解可使CS-81002的分子量下降,分支减少,并且对巨噬细胞吞噬功能的促进作用亦有下降趋势。在所得到的各个部份酸水解级分(分子量分别为41000,40000,32000,16000和12000)中,分子量为12000的级分对巨噬细胞吞噬功能无促进作用。